![Brennan Doyle](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Brennan Doyle is currently the Investor Relations Contact at Harmony Biosciences Holdings, Inc. since 2024.
Formerly, Mr. Doyle was the Investor Relations Contact at BioXcel Therapeutics, Inc. from 2022 to 2024.
Postes actifs de Brennan Doyle
| Sociétés | Poste | Début |
|---|---|---|
| HARMONY BIOSCIENCES HOLDINGS, INC. | Investor Relations Contact | 01/06/2024 |
Anciens postes connus de Brennan Doyle
| Sociétés | Poste | Fin |
|---|---|---|
| BIOXCEL THERAPEUTICS, INC. | Investor Relations Contact | 01/05/2024 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
3
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
BioXcel Therapeutics, Inc.
 BioXcel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops transformative medicines in neuroscience and immuno-oncology | Health Technology |
Harmony Biosciences Holdings, Inc.
 Harmony Biosciences Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for patients living with rare neurological disorders | Health Technology |
Choisissez Zonebourse 
